Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis.
Lung transplantation is the only intervention shown to increase life expectancy for patients …

First performed in 1963, lung transplantation is approaching the half-century mark. With
more than 32,000 procedures having been performed worldwide, lung transplantation has …

An international conference of transplant physicians, surgeons, and allied health
professionals was held in Vancouver, Canada, on September 15 and 16, 2005 to address …

The 2007 American Society of Transplant Surgeons'(ASTS) State-of-the-Art Winter
Symposium entitled,'Solving the Organ Shortage Crisis' explored ways to increase the …

Living-donor lobar lung transplantation (LDLLT) was developed to deal with the severe
shortage of brain dead door for patients who would not survive the long waiting period. In …

Lung transplantations that utilize donor organs after cardiac death (DCD) can substantially
increase the number of available allografts for waiting recipients. Unfortunately, reported …

Pediatric lung and heart-lung transplantation are viable therapeutic interventions for end
stage pulmonary parenchymal or pulmonary vascular diseases. Issues specific to pediatrics …

Background Successful living-donor lobar lung transplantation largely depends on the
donor's outcome. Because surgical skills and peri-operative management have evolved …

BACKGROUND: Although new approaches to the treatment of patients with cystic fibrosis
(CF) are significantly prolonging their lives, most patients will eventually develop respiratory …

During the past two decades, several advances have resulted in marked improvement in
medium-term survival for infants and children undergoing heart transplantation …